Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Robert Hunt
13 Nov 2025
Chief Accounting Officer
Buy
11,000
$2.03
$22.29K
Robert F Williamson III
12 Nov 2025
Director
Buy indirect
9,498
$2.10
$19.95K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 0
History held since 26 Oct 2006